e-learning
resources
London 2016
Tuesday, 06.09.2016
Orphan diseases II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Katrin Esther Hostettler (Basel, Switzerland), Katrin Esther Hostettler Haack, Jörg Halter, Michael Tamm
Source:
International Congress 2016 – Orphan diseases II
Session:
Orphan diseases II
Session type:
Thematic Poster
Number:
3923
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Katrin Esther Hostettler (Basel, Switzerland), Katrin Esther Hostettler Haack, Jörg Halter, Michael Tamm. Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. Eur Respir J 2016; 48: Suppl. 60, 3923
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation
Source: Eur Respir J 2011; 38: 470-472
Year: 2011
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004
Bronchiolitis obliterans following haematopoietic stem cell transplantation
Source: Eur Respir J 2007; 29: 1007-1019
Year: 2007
Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant
Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017
Year: 2018
Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
Source: Eur Respir J 2005; 25: 402-405
Year: 2005
Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018
Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
Source: Eur Respir J 2014; 43: 221-232
Year: 2004
Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
Source: Eur Respir J 2005; 25: 490-493
Year: 2005
Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017
Year: 2018
LATE-BREAKING ABSTRACT: Nitrogen multiple breath washout for diagnosis of biopsy-proven bronchiolitis obliterans in patients after allogeneic stem cell transplantation
Source: International Congress 2016 – Dyspnoea and respiratory muscle/mechanics anomalies in disease
Year: 2016
Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 476s
Year: 2002
Noninfectious pulmonary complications of haematopoietic stem cell transplantation
Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019
Year: 2020
Bronchiolitis obliterans identified by inert gas washout following allogenic stem-cell transplantation in children
Source: Annual Congress 2007 - Clinical applications of lung function testing in children
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept